The original success of Viagra undeniably reshaped the pharmaceutical landscape, but betting in companies primarily reliant on generic versions presents a complex picture. Although early earnings were impressive, the expiration of patents and the appearance of less expensive alternatives have eroded the customer base. Consequently, a thorough asses